You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)

Suspended
  • Amyloid
  • +2 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
May 17, 2022

Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

Not yet recruiting
  • Steroid-refractory Acute Graft-versus-host Disease
  • MC0518
  • BAT
  • (no location specified)
Oct 4, 2023

Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)

Completed
  • Steroid Refractory GVHD
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Dec 15, 2022

Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease Trial in United States

Completed
  • Steroid-refractory Acute Graft-versus-Host Disease
  • Treatment-refractory Acute Graft-versus-Host Disease
  • Neihulizumab (ALTB-168)
  • Duarte, California
  • +12 more
Jan 17, 2023

Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Seattle (Nivolumab)

Recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +17 more
  • Nivolumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Minimal Residual Disease Trial (Venetoclax, Decitabine,

Not yet recruiting
  • Relapsed Acute Myeloid Leukemia
  • +2 more
  • Venetoclax, Decitabine, Azacytidine, Cytarabine
  • (no location specified)
May 4, 2022

A PMS of Jakavi® in Steroid-Refractory Graft-versus-Host Disease

Not yet recruiting
  • Graft-versus-Host Disease
  • ruxolitinib
  • (no location specified)
Jan 11, 2023

Relapsed or Refractory Hodgkin Lymphoma Trial in Beijing (SHR2554+ SHR1701, SHR-1701)

Recruiting
  • Relapsed or Refractory Hodgkin Lymphoma
  • Beijing, Beijing, China
    Han wei dong
Jun 14, 2023

Parkinson Disease Trial in Stanford (Vibrotactile Coordinated Reset (vCR))

Not yet recruiting
  • Parkinson Disease
  • Vibrotactile Coordinated Reset (vCR)
  • Stanford, California
    Stanford University
Sep 28, 2022

Nontuberculous Mycobacterium Infection, Mycobacterium Abscessus Infection Trial (Delpazolid)

Not yet recruiting
  • Nontuberculous Mycobacterium Infection
  • Mycobacterium Abscessus Infection
  • (no location specified)
Aug 21, 2023

Crohn Disease Trial in Wuhan (Standardized FMT)

Recruiting
  • Crohn Disease
  • Standardized FMT
  • Wuhan, Hubei, China
    Tongji Hospital
Dec 18, 2022

SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)

Recruiting
  • SLE (Systemic Lupus)
  • +4 more
  • CD19 targeted CAR-T cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Sep 25, 2023

Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm
  • +2 more
  • Decidual stromal cells (DSC)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Gastro-esophageal Reflux, Reflux, Gastroesophageal Trial in Garmisch-Partenkirchen (Anti Reflux Mucosa Ablation)

Not yet recruiting
  • Gastro-esophageal Reflux
  • Reflux, Gastroesophageal
  • Anti Reflux Mucosa Ablation
  • Garmisch-Partenkirchen, Bayern, Germany
    Klinikum Garmisch-Partenkirchen
Jul 13, 2022

GVHD,Acute Trial (OSSM-001)

Withdrawn
  • GVHD,Acute
  • OSSM-001
  • (no location specified)
Dec 21, 2022

Myocardial Ischemia After Coronary Sinus Reduction Stent

Not yet recruiting
  • Angina Pectoris
  • Coronary sinus reduction stent
  • (no location specified)
Sep 5, 2023

Gastroesophageal Reflux Disease With Ulceration Trial in Marseille (endoscopic mucosal resection, sham)

Recruiting
  • Gastroesophageal Reflux Disease With Ulceration
  • endoscopic mucosal resection
  • sham
  • Marseille, France
    AP-HM
Feb 15, 2023

Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG

Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Brentuximab Vedotin 50 MG [Adcetris]
  • Leon, Guanajuato, Mexico
    Hospital Regional Alta Especialidad Bajio
Oct 24, 2022

Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Steroid Refractory Graft Versus Host Disease
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

T-lymphoblastic Lymphoma, Relapsed Disease, Refractory Lymphoma Trial in Shanghai (BCL2 Inhibitor plus IM2 regimen)

Recruiting
  • T-lymphoblastic Lymphoma
  • +5 more
  • BCL2 Inhibitor plus IM2 regimen
  • Shanghai, Shanghai, China
    Shanghai General hospital,Shanghai Jiao Tong University School o
Jan 10, 2023

Refractory Reflux Esophagitis Trial in Xi'an (Trimebutine Maleate, rabeprazole)

Withdrawn
  • Refractory Reflux Esophagitis
  • Xi'an, Shaanxi, China
    Xijing Hosipital of Digestive Disease
Jan 30, 2023

Chronic GVHD Trial in Duarte (biological, procedure, other)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Aldesleukin
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Boston (Nivolumab, Ipilimumab)

Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Boston, Massachusetts
  • +2 more
Oct 18, 2022

Movement Disorders, Essential Tremor, Holmes Tremor Trial in Toronto (Transcranial ExAblate System)

Active, not recruiting
  • Movement Disorders
  • +8 more
  • Transcranial ExAblate System
  • Toronto, Ontario, Canada
  • +1 more
Dec 19, 2022

Coronary Artery Disease, Angina Pectoris, Myocardial Ischemia Trial in Ostrava, Trinec (Radiosurgery of ganglion stellatum)

Recruiting
  • Coronary Artery Disease
  • +2 more
  • Radiosurgery of ganglion stellatum
  • Ostrava, Moravian-Silesian Region, Czechia
  • +1 more
Oct 31, 2022